CRBU
Price
$0.77
Change
-$0.02 (-2.53%)
Updated
May 9 closing price
Capitalization
72.01M
93 days until earnings call
FULC
Price
$5.37
Change
-$0.04 (-0.74%)
Updated
May 9 closing price
Capitalization
289.87M
87 days until earnings call
Ad is loading...

CRBU vs FULC

Header iconCRBU vs FULC Comparison
Open Charts CRBU vs FULCBanner chart's image
Caribou Biosciences
Price$0.77
Change-$0.02 (-2.53%)
Volume$932.75K
Capitalization72.01M
Fulcrum Therapeutics
Price$5.37
Change-$0.04 (-0.74%)
Volume$537.28K
Capitalization289.87M
CRBU vs FULC Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FULC commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FULC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CRBU: $0.77 vs. FULC: $5.37)
Brand notoriety: CRBU and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 90% vs. FULC: 101%
Market capitalization -- CRBU: $72.01M vs. FULC: $289.87M
CRBU [@Biotechnology] is valued at $72.01M. FULC’s [@Biotechnology] market capitalization is $289.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 6 TA indicator(s) are bullish while FULC’s TA Score has 6 bullish TA indicator(s).

  • CRBU’s TA Score: 6 bullish, 2 bearish.
  • FULC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than FULC.

Price Growth

CRBU (@Biotechnology) experienced а -12.01% price change this week, while FULC (@Biotechnology) price change was -4.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($290M) has a higher market cap than CRBU($72M). FULC YTD gains are higher at: 14.255 vs. CRBU (-51.302). FULC has higher annual earnings (EBITDA): -18.24M vs. CRBU (-162.69M). FULC has more cash in the bank: 241M vs. CRBU (210M). FULC has less debt than CRBU: FULC (8.63M) vs CRBU (26.5M). FULC has higher revenues than CRBU: FULC (80M) vs CRBU (9.99M).
CRBUFULCCRBU / FULC
Capitalization72M290M25%
EBITDA-162.69M-18.24M892%
Gain YTD-51.30214.255-360%
P/E RatioN/AN/A-
Revenue9.99M80M12%
Total Cash210M241M87%
Total Debt26.5M8.63M307%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFULC
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
89%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMKX10.340.05
+0.49%
BNY Mellon Emerging Markets M
RSPKX22.380.03
+0.13%
Victory RS Partners R
MDSCX11.930.01
+0.08%
BlackRock Sustainable Advantage Gl EqIns
PNOYX129.44-0.12
-0.09%
Putnam Sustainable Leaders Y
DWOAX18.01-0.07
-0.39%
BNY Mellon Research Growth A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-0.74%
SLS - FULC
48%
Loosely correlated
-7.14%
ANNX - FULC
40%
Loosely correlated
-5.88%
VRDN - FULC
39%
Loosely correlated
-3.05%
NKTX - FULC
36%
Loosely correlated
-1.03%
MLTX - FULC
34%
Loosely correlated
-3.20%
More